Investor Presentaiton

The need for therapy selection in oncology is growing rapidly GUARDANT™ Larger patient population Earlier use of therapies Expanding utility in additional cancers Greater need for biomarker testing across all cancers Treatment Window More lines of therapies More tests per patient as survival improves 99 56 INVESTOR 20 DAY 23

View entire presentation